Increased circulating concentrations of RBP-4 have been linked with increased visceral adiposity [16] and have been shown to directly contribute to hepatic insulin resistance via induction of hepatic glucose production [17] and impairment of insulin signaling in muscle [15,18]. The gene discussed is RBP4; the disease is Insulin resistance.